New Report Covers Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017

Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Disposable Hospital Supplies currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Disposable Hospital Supplies pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Disposable Hospital Supplies under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Disposable Hospital Supplies and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Disposable Hospital Supplies under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Cantel Medical Corp. Cascade Metrix, Inc. Deton Corp. Elcam Medical Fosmo Med, Inc. H. Lee Moffitt Cancer Center & Research Institute Inc Linear Health Sciences LLC Lineus Medical Nanyang Polytechnic International Pvt Ltd Rutgers The State University of New Jersey Stanford University University of California Irvine University of Illinois University of Missouri University of Pennsylvania

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

In-Depth Research on Implantable Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2017

Implantable Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Implantable Remote Patient Monitoring Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Remote Patient Monitoring Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Implantable Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Implantable Remote Patient Monitoring Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Implantable Remote Patient Monitoring Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Remote Patient Monitoring Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Boston Scientific Corp Ludwig-Maximilians-University Munich NeuroVista Corp Profusa, Inc. St. Jude Medical LLC Toumaz Technology Limited

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Recent Report on Wireless and Ambulatory Monitoring - Medical Devices Pipeline Assessment, 2017

Wireless and Ambulatory Monitoring - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Wireless and Ambulatory Monitoring currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wireless and Ambulatory Monitoring pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Wireless and Ambulatory Monitoring - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Wireless and Ambulatory Monitoring under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Wireless and Ambulatory Monitoring and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Wireless and Ambulatory Monitoring under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Aclaris Medical, LLC DoseCue, LLC Ecole Polytechnique Federale de Lausanne Empatica Inc. HMicro Inc Mayo Clinic US Physical Activity Innovations, Inc. Stanford University University of California Los Angeles University of California San Diego University of Michigan University of Michigan Pediatric Device Consortium

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

In-Depth Review on Total Artificial Heart - Medical Devices Pipeline Assessment, 2017

Total Artificial Heart - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Total Artificial Heart currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Total Artificial Heart pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Total Artificial Heart - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Total Artificial Heart under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Total Artificial Heart under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Abiomed Inc BiVacor Pty Ltd Carmat SAS Cleveland Heart Inc Foster-Miller, Inc. Indian Institute of Technology Delhi ReliantHeart, Inc. SynCardia Systems, Inc. The University of Tokyo

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Detailed Report on Central Venous Catheters - Medical Devices Pipeline Assessment, 2017

Central Venous Catheters - Medical Devices Pipeline Assessment, 2017is a new market research publication announced by Reportstack. This report provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Central Venous Catheters - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Central Venous Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Central Venous Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Ash Access Technology Inc Bactiguard AB Bluegrass Vascular Technologies Inc Charite - Universitatsmedizin Berlin Globe Medical Tech Inc i360medical Limited Infusense Corp Marvao Medical Devices Limited Nipro Corp Pavmed Inc S3V Vascular Technologies Sharklet Technologies, Inc. Silver Bullet Therapeutics, Inc. Teleflex Inc The University of Utah University of Illinois at Chicago Vascular Access Technologies, Inc. Vindica Therapeutics, Inc

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

New Research Explores on Arterial Calcification Global Clinical Trials Review, H1, 2017

Arterial Calcification Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Arterial Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Calcification. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Arterial Calcification Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Medestea Internazionale SpA Shire Plc Sanofi Orkla ASA Novartis AG Monash Health Laboratoris Sanifit SL Clinipace Worldwide Inc Amgen Inc Alexion Pharmaceuticals Inc

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Detailed Study of the Arterial Stiffness Global Clinical Trials Review, H1, 2017

Arterial Stiffness Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Arterial Stiffness Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

AstraZeneca Plc Astellas Pharma Inc Eli Lilly and Company Cell-Logic Pty Ltd BioMarin Pharmaceutical Inc Bayer AG Appledown Clinical Research Ltd Amgen Inc Allergan Plc A. Menarini Industrie Farmaceutiche Riunite Srl

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Recent Research into the Arterial Thrombosis Global Clinical Trials Review, H1, 2017

Arterial Thrombosis Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Arterial Thrombosis Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Bayer AG AstraZeneca Plc Johnson & Johnson Thromboserin Ltd Takeda Pharmaceutical Company Ltd Quintiles IMS Holdings Inc Celerion Inc Bristol-Myers Squibb Company Arena Pharmaceuticals Inc Alfred E. Tiefenbacher (GmbH & Co KG)

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###